Trials / Conditions / HIV-infection/Aids

HIV-infection/Aids

22 registered clinical trials studyying HIV-infection/Aids — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Interventio NCT05947539	Arizona State University	N/A
Completed	WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP) NCT04373551	University of Alabama at Birmingham	N/A
Withdrawn	Inflammation and Co-Infections in D²EFT NCT04183738	Kirby Institute	Phase 4
Completed	Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Ug NCT03919695	San Diego State University	N/A
Completed	COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings NCT04371835	Kirby Institute	—
Unknown	Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection NCT04297488	Peking Union Medical College Hospital	N/A
Unknown	Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients NCT04303598	Henan Genuine Biotech Co., Ltd.	Phase 3
Unknown	NAFLD in HIV-infected Patients NCT04215926	Shanghai Public Health Clinical Center	—
Completed	Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection NCT03403569	Peking Union Medical College Hospital	Phase 3
Completed	The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HI NCT03794648	National University Hospital, Singapore	N/A
Unknown	Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection NCT03147859	Ottawa Hospital Research Institute	Phase 2
Unknown	Adherence Connection for Counseling, Education, and Support NCT02753049	New York University	N/A
Withdrawn	Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial NCT01442428	University of Minnesota	Phase 2 / Phase 3
Completed	Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam NCT01827540	Tobira Therapeutics, Inc.	Phase 1
Completed	Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care NCT01406626	University of California, Los Angeles	N/A
Completed	Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program NCT03069235	Johns Hopkins University	N/A
Completed	Community-Based Peer Facilitator Intervention (Zimbabwe) NCT02496793	Elizabeth Glaser Pediatric AIDS Foundation	N/A
Completed	Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study NCT01360762	Institute of Tropical Medicine, Belgium	Phase 3
Completed	Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA NCT02433743	Cheikh Anta Diop University, Senegal	N/A
Completed	Vitamin D Supplementation in HIV NCT01475890	Children's Hospital of Philadelphia	Phase 2 / Phase 3
Completed	Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda NCT01140633	Massachusetts General Hospital	—
Completed	Healthy Teen Girls: HIV Risk Reduction NCT00787696	Mississippi State University	Phase 1 / Phase 2